Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 106

1.

CD200 Expression Marks a Population of Quiescent Limbal Epithelial Stem Cells with Holoclone Forming Ability.

Bojic S, Hallam D, Alcada N, Ghareeb A, Queen R, Pervinder S, Buck H, Amitai Lange A, Figueiredo G, Rooney P, Stojkovic M, Shortt A, Figueiredo FC, Lako M.

Stem Cells. 2018 Nov;36(11):1723-1735. doi: 10.1002/stem.2903. Epub 2018 Oct 1.

2.

Stem Cells Therapy for Spinal Cord Injury.

Gazdic M, Volarevic V, Harrell CR, Fellabaum C, Jovicic N, Arsenijevic N, Stojkovic M.

Int J Mol Sci. 2018 Mar 30;19(4). pii: E1039. doi: 10.3390/ijms19041039. Review.

3.

Intraperitoneal administration of mesenchymal stem cells ameliorates acute dextran sulfate sodium-induced colitis by suppressing dendritic cells.

Nikolic A, Simovic Markovic B, Gazdic M, Randall Harrell C, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, L Lukic M, Stojkovic M, Volarevic V.

Biomed Pharmacother. 2018 Apr;100:426-432. doi: 10.1016/j.biopha.2018.02.060. Epub 2018 Feb 22.

PMID:
29471245
4.

Ethical and Safety Issues of Stem Cell-Based Therapy.

Volarevic V, Markovic BS, Gazdic M, Volarevic A, Jovicic N, Arsenijevic N, Armstrong L, Djonov V, Lako M, Stojkovic M.

Int J Med Sci. 2018 Jan 1;15(1):36-45. doi: 10.7150/ijms.21666. eCollection 2018. Review.

5.

Mesenchymal Stem Cell-Dependent Modulation of Liver Diseases.

Gazdic M, Arsenijevic A, Markovic BS, Volarevic A, Dimova I, Djonov V, Arsenijevic N, Stojkovic M, Volarevic V.

Int J Biol Sci. 2017 Sep 5;13(9):1109-1117. doi: 10.7150/ijbs.20240. eCollection 2017. Review.

6.

Stem Cell-Based Therapy in Transplantation and Immune-Mediated Diseases.

Volarevic V, Lako M, Erceg S, Stojkovic M.

Stem Cells Int. 2017;2017:7379136. doi: 10.1155/2017/7379136. Epub 2017 Sep 6. No abstract available.

7.

hiPSC Disease Modeling of Rare Hereditary Cerebellar Ataxias: Opportunities and Future Challenges.

Lukovic D, Moreno-Manzano V, Rodriguez-Jimenez FJ, Vilches A, Sykova E, Jendelova P, Stojkovic M, Erceg S.

Neuroscientist. 2017 Oct;23(5):554-566. doi: 10.1177/1073858416672652. Epub 2016 Oct 6. Review.

PMID:
28281409
8.

Highly Efficient Neural Conversion of Human Pluripotent Stem Cells in Adherent and Animal-Free Conditions.

Lukovic D, Diez Lloret A, Stojkovic P, Rodríguez-Martínez D, Perez Arago MA, Rodriguez-Jimenez FJ, González-Rodríguez P, López-Barneo J, Sykova E, Jendelova P, Kostic J, Moreno-Manzano V, Stojkovic M, Bhattacharya SS, Erceg S.

Stem Cells Transl Med. 2017 Apr;6(4):1217-1226. doi: 10.1002/sctm.16-0371. Epub 2017 Feb 18.

9.

Comprehensive surgical. Orthodontic treatment of class III malocclusion in cleft patient involving minimally invasive surgery Case report and literature review.

Stojkovic G, Stojkovic M, Stojkovic J, Nikolic D, Stajcic Z.

Ann Ital Chir. 2016 Dec 19;5. pii: S2239253X16026384. Review.

PMID:
28098566
10.

Stem Cells and Labeling for Spinal Cord Injury.

Gazdic M, Volarevic V, Arsenijevic A, Erceg S, Moreno-Manzano V, Arsenijevic N, Stojkovic M.

Int J Mol Sci. 2016 Dec 26;18(1). pii: E6. doi: 10.3390/ijms18010006. Review.

11.

Connexin 50 modulates Sox2 expression in spinal-cord-derived ependymal stem/progenitor cells.

Rodriguez-Jimenez FJ, Alastrue A, Stojkovic M, Erceg S, Moreno-Manzano V.

Cell Tissue Res. 2016 Aug;365(2):295-307. doi: 10.1007/s00441-016-2421-y. Epub 2016 May 24.

PMID:
27221278
12.

Pharmacological Inhibition of Gal-3 in Mesenchymal Stem Cells Enhances Their Capacity to Promote Alternative Activation of Macrophages in Dextran Sulphate Sodium-Induced Colitis.

Simovic Markovic B, Nikolic A, Gazdic M, Nurkovic J, Djordjevic I, Arsenijevic N, Stojkovic M, Lukic ML, Volarevic V.

Stem Cells Int. 2016;2016:2640746. doi: 10.1155/2016/2640746. Epub 2016 Jan 4.

13.

Stem Cells, Inflammation, and Fibrosis.

Volarevic V, Lako M, Stojkovic M.

Stem Cells Int. 2016;2016:3891386. doi: 10.1155/2016/3891386. Epub 2016 Feb 24. No abstract available.

14.

Primordial Germ Cells: Current Knowledge and Perspectives.

Nikolic A, Volarevic V, Armstrong L, Lako M, Stojkovic M.

Stem Cells Int. 2016;2016:1741072. doi: 10.1155/2016/1741072. Epub 2015 Nov 9. Review.

15.

Connexin 50 Expression in Ependymal Stem Progenitor Cells after Spinal Cord Injury Activation.

Rodriguez-Jimenez FJ, Alastrue-Agudo A, Stojkovic M, Erceg S, Moreno-Manzano V.

Int J Mol Sci. 2015 Nov 6;16(11):26608-18. doi: 10.3390/ijms161125981.

16.

Aging of Stem and Progenitor Cells: Mechanisms, Impact on Therapeutic Potential, and Rejuvenation.

Nurkovic J, Volarevic V, Lako M, Armstrong L, Arsenijevic N, Stojkovic M.

Rejuvenation Res. 2016 Feb;19(1):3-12. doi: 10.1089/rej.2015.1676. Review.

PMID:
26055182
17.

Concise Review: Cardiac Disease Modeling Using Induced Pluripotent Stem Cells.

Yang C, Al-Aama J, Stojkovic M, Keavney B, Trafford A, Lako M, Armstrong L.

Stem Cells. 2015 Sep;33(9):2643-51. doi: 10.1002/stem.2070. Epub 2015 Jun 23. Review.

18.

Complete rat spinal cord transection as a faithful model of spinal cord injury for translational cell transplantation.

Lukovic D, Moreno-Manzano V, Lopez-Mocholi E, Rodriguez-Jiménez FJ, Jendelova P, Sykova E, Oria M, Stojkovic M, Erceg S.

Sci Rep. 2015 Apr 10;5:9640. doi: 10.1038/srep09640.

19.

Concise review: reactive astrocytes and stem cells in spinal cord injury: good guys or bad guys?

Lukovic D, Stojkovic M, Moreno-Manzano V, Jendelova P, Sykova E, Bhattacharya SS, Erceg S.

Stem Cells. 2015 Apr;33(4):1036-41. doi: 10.1002/stem.1959. Review.

20.

Mesenchymal stem cells: a friend or foe in immune-mediated diseases.

Gazdic M, Volarevic V, Arsenijevic N, Stojkovic M.

Stem Cell Rev Rep. 2015 Apr;11(2):280-7. doi: 10.1007/s12015-014-9583-3. Review.

PMID:
25592610

Supplemental Content

Loading ...
Support Center